OBJECTIVES
During the Feasibility Study conducted in Phase 1 critique article thesis statement about the death penalty we conducted an assessment of the technology needs to bring QUIBIM from the current TRL7 to TRL9. As a result, the study concluded that for a successful development of the project, during Phase 2, a block of business objectives and three main technical objectives should be addressed in order to make QUIBIM fully commercially ready for the international market:
OBJECTIVE 1
Improvement in product functionalities in 3 key areas
- Improvement in imaging biomarkers
- Data visualization
- Translation of the platform and structured report
OBJECTIVE 2
Improvement in product capabilities
- Computing performance
OBJECTIVE 3
Product integration and demonstration
- Integration of the new modules and functionalities and general optimization of the platform
- Demonstration pilots with end-users and industry representatives
OBJECTIVE 4
Development of Business objectives
- IPR Management
- Regulatory certification
- Operations Plan to scale the company
- Business expansion and innovation plans